Gonadotropin-releasing hormone neurons in the preoptic-hypothalamic region of the rat contain lamprey gonadotropin-releasing hormone III, mammalian luteinizing hormone-releasing hormone, or both peptides by J. K. Hiney et al.
Gonadotropin-releasing hormone neurons in the
preoptic-hypothalamic region of the rat contain
lamprey gonadotropin-releasing hormone III,
mammalian luteinizing hormone-releasing
hormone, or both peptides
J. K. Hiney*†, S. A. Sower‡, W. H. Yu§, S. M. McCann§, and W. L. Dees*
*Department of Veterinary Anatomy and Public Health, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843-4458;
‡Department of Biochemistry and Molecular Biology, University of New Hampshire, Biological Science Center, Durham, NH 03824; and
§Pennington Biomedical Research Center, Louisiana State University, Perkins Road, Baton Rouge, LA 70808-4124
Contributed by S. M. McCann, December 26, 2001
This study utilized a newly developed antiserum, specific for
lamprey gonadotropin-releasing hormone III (l-GnRH-III), to deter-
mine the following: in which regions of the rat hypothalamus the
neuronal perikarya producing l-GnRH-III are localized; and whether
this peptide, known to selectively induce follicle-stimulating hor-
mone release, is coexpressed in neurons containing mammalian
luteinizing hormone-releasing hormone (m-LHRH). Double-label
immunocytochemistry was performed by using an l-GnRH-III poly-
clonal antiserum and an LHRH monoclonal antiserum. Immunopo-
sitive neurons for l-GnRH-III, m-LHRH, or neurons coexpressing
both peptides were detected within the organum vasculosum
lamina terminalis (OVLT) region of the preoptic area (POA). Caudal
to the OVLT, l-GnRH-III-positive neurons were also observed dorso-
medially, above the third ventricle in the medial POA. The m-LHRH
neurons were not observed in this area. The lateral POA region
contained neurons positive for both peptides along with single-
labeled neurons for each peptide. Importantly, neurons that ex-
pressed l-GnRH-III, m-LHRH, or both peptides were also detected in
the ventral regions of the rostral hypothalamus, dorsolateral to the
borders of the supraoptic nuclei. In both of these latter areas,
neurons containing l-GnRH-III were slightly dorsal to neurons
containing only m-LHRH. The l-GnRH-III perikarya and fibers were
eliminated by absorption of the primary antiserum with l-GnRH-III,
but not by l-GnRH-I, chicken-GnRH-II, or m-LHRH. These results
indicate that, unlike other isoforms of GnRH found in the mam-
malian brain, l-GnRH-III neurons not only are observed in regions
that control follicle-stimulating hormone release but also are
colocalized with m-LHRH neurons in areas primarily controlling LH
release. These findings suggest an interrelationship between these
two peptides in the control of gonadotropin secretion.
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Gonadotropin-releasing hormones (GnRHs) have been de-tected in all vertebrate species studied across the phyloge-
netic scale from tunicates (1, 2) to humans (2, 3). In mammals,
the prevailing view is that luteinizing hormone (LH) and follicle-
stimulating hormone (FSH) release is primarily controlled by
mammalian luteinizing hormone-releasing hormone (m-
LHRH). However, recent studies have uncovered other isoforms
of the GnRH peptide besides m-LHRH in the mammalian brain
(3–8). Chicken-GnRH-II (c-GnRH-II) (4–7) and lamprey-
GnRH (l-GnRH; refs. 3 and 8) have been detected in the
mammalian hypothalamus. Specifically, in situ hybridization
experiments localized c-GnRH-II mRNA in the supraoptic,
paraventricular, and suprachiasmatic nuclei as well as in the
medial basal hypothalamus, but this mRNA was not detected
within neurons that were immunopositive for m-LHRH (5).
With regard to l-GnRH, an antiserum to l-GnRH-I bound to
cells and nerve fibers projecting through the arcuate nucleus and
terminating in the median eminence (ME) in the human brain
(3). Additionally, our recent study using an antibody that rec-
ognized both l-GnRH-I and l-GnRH-III allowed us to visualize
a l-GnRH system in the preoptic-hypothalamic areas of the rat
brain that control FSH release (8).
All of these GnRH forms have the ability to release LH;
however, only l-GnRH-III has been shown to be a potent,
selective inducer of FSH release, as shown in the rat (9) and cow
(10). In contrast, l-GnRH-I is ineffective (11) and c-GnRH-II
has only slight preferential FSH-releasing activity in vivo (12),
but not in vitro (9). Consequently, because our previous study
showed the presence of l-GnRH-like neurons in regions of the
hypothalamus that also contain an abundance of m-LHRH
neurons (8), we used a double-label immunocytochemical tech-
nique using a new antiserum specific to l-GnRH-III to determine
the relationship between the m-LHRH and l-GnRH-III neuro-
nal populations.
Methods
Tissue Preparation. Adult male Sprague–Dawley rats were pur-
chased from Charles River Breeding Laboratories. Each rat was
anesthetized with 2.5% tribromoethanol and implanted with a
third ventricular cannula as described previously (13). While still
under anesthesia, an injection of colchicine (100 g3 l) was
administered into the third ventricular cannula. The following
day, animals were anesthetized with 2.5% tribromoethanol,
f lushed with saline via cardiac perfusion, and fixed with 4%
paraformaldehyde. The brains were removed and postfixed
overnight in the same fixative, then rinsed in potassium PBS
(KPBS, ph 7.4). Forty-micrometer adjacent sections starting
rostrally at regions containing the diagonal band of Broca and
proceeding caudally to sections containing the anterior hypo-
thalamus and mammillary nuclei were made by using a vi-
bratome. Sections were also used from the mesencephalon
containing the mesencephalic aqueduct.
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l-GnRH-III Immunocytochemistry. Sections were incubated in 1%
H2O2 for 60 min. Immunocytochemistry for l-GnRH-III was
performed as previously described (8), except for the primary
antiserum. The antiserum to l-GnRH-III was generated in
rabbits by S.A.S. (Code No. 39-82-78-3). The specificity of the
antiserum for l-GnRH-III was tested by immunocytochemistry,
and showed no cross-reactivity with l-GnRH-I in the lamprey.
Preabsorption of this antiserum with l-GnRH-I also had no
affect on the antiserum binding to l-GnRH-III in the lamprey
(S.A.S., unpublished observations). Anti-BSA activity was elim-
inated from this antibody by the addition of 500 g of BSA to a
1:100 dilution of the antiserum 24 h before use. Subsequently,
the antiserum was diluted 1:1000 with KPBS B (KPBS with 1.5%
normal goat serum and 0.5% Triton X-100), then incubated with
tissues 48 h at 4 C. Tissues were rinsed and then incubated for
1 h and 15 min in biotinylated goat anti-rabbit IgG (1:500, Vector
Laboratories). After washing, the tissues were incubated in
avidin biotin complex (ABC, Vector Laboratories) for 30 min at
room temperature. After washes in KPBS, the signal was am-
plified by using a biotin amplification procedure (14) by incu-
bating for 20 min in 0.01% H2O2 and biotinylated tyramine (BT,
10 lml). Tissues were rinsed again in KPBS and then incu-
bated in ABC for 60 min at 37 C, rinsed in KPBS, and then
washed with sodium acetate buffer (0.175 M; 3 times for 10 min).
The sections were exposed to sodium acetate buffer containing
0.02% 3,3-diaminobenzidine tetrahydrochloride (DAB) and
0.03% H202 and 1.25% nickel sulfate (Ni-DAB) for 2–5 min and
then rinsed in sodium acetate buffer followed by KPBS buffer.
The sections were mounted on gelatin coated slides, dehydrated
in graded alcohols, cleared in Histoclear (VWR Scientific),
coverslipped, and viewed on a Leitz microscope.
Specificity of the l-GnRH-III antiserum was tested by preab-
sorbing the serum with synthetic l-GnRH-III peptide synthesized
by M. L. Yuban (Louisiana State University, Baton Rouge, LA),
l-GnRH-I (Peninsula Laboratories), m-LHRH (human LHRH,
Sigma), c-GnRH-II (Bachem) at concentrations ranging from
1–10 g0.1 ml of l-GnRH antiserum (1:100 dilution) for 24 h.
A final dilution of 1:1000 was used for all assessments.
Double Immunocytochemistry Technique. Colocalization of l-
GnRH-III and m-LHRH was performed by using double im-
munocytochemistry procedure by using Ni-DAB chromagen
(blackblue stain) followed by the DAB chromagen (brown
stain). Sections were processed as above to detect l-GnRH-III
neurons and fibers by using the Ni-DAB chromagen. After the
tissues were exposed to the Ni-DAB chromagen, they were
washed in KPBS buffer and then incubated overnight at room
temperature with a monoclonal LHRH antiserum (1:500,
HU11B, provided by H. Urbanski, Oregon Regional Primate
Center, Beaverton, OR). The sections were rinsed in KPBS B
buffer (1.5% normal horse serum, 0.05% Triton X-100) and then
incubated at room temperature with biotinylated anti-mouse
Fig. 1. Localization of l-GnRH-III and m-LHRH in the rostral region of the POA. (A) Distribution of l-GnRH-III and m-LHRH nerve fibers and perikarya in the lamina
terminalis. Note that l-GnRH-III neurons (black; red arrows) are interspersed among the m-LHRH neurons (brown; black arrows) and those that express both
peptides (blackbrown; arrowheads). Fiber tracts for l-GnRH-III (black) and m-LHRH (brown) are shown within the OVLT. (B) An increased magnification of three
neurons shown in the box in A. Two of the neurons are immunopositive for both l-GnRH-III and m-LHRH (blackbrown; arrowheads), and one neuron is
immunopositive only for m-LHRH (brown; black arrow). (C) The morphology of two l-GnRH-III positive neurons (black; red arrows) and one neuron containing
both l-GnRH-III and m-LHRH (blackbrown; arrowhead). (A, 144; B, 305; C, 322.)







IgG (1:500 dilution, Vector Laboratories) for 1 h. Sections were
rinsed in KPBS then incubated with ABC complex for 1.5 h. The
sections were rinsed and then incubated with DAB (10 mg
DAB50 mls KPBS0.03% H202) for 5 min. Sections were
mounted on gelatin coated slides, dehydrated in graded alcohols,
cleared in Histoclear, coverslipped, and viewed microscopically.
Microscopy was performed with a Zeiss Axioplan2 micro-
scope fitted with a Hamamatsu chilled 3CCD color camera
(Hamamatsu, Bridgewater, NJ). Digital images were captured by
using Adobe Photoshop 4.0 (Adobe Systems, Seattle, WA) and
MacIntosh PowerMac G3 computer (Apple Computer, Cuper-
tino, CA). Prints were electronically printed by using a Kodak
DS8650 color printer.
Results
Double-labeled immunocytochemistry was used to compare the
localization of l-GnRH-III peptide with that of m-LHRH in the
rat hypothalamus. L-GnRH-III was detected by using the nickel-
intensified DAB stain, which shows a black reaction product, and
m-LHRH was detected by using the DAB without nickel, which
shows a brown reaction product. Fig. 1 A–C illustrates the
localization of l-GnRH-III and m-LHRH nerve fibers and
perikarya in the lamina terminalis region of the preoptic area
(POA). Neurons containing both black and brown chromagen
are immunopositive for both peptides, whereas neurons con-
taining only black chromagen are immunopositive for l-GnRH-
III and neurons containing only brown chromagen are immu-
nopositive for m-LHRH. L-GnRH-III perikarya are similar in
morphology to the m-LHRH perikarya in that they are bipolar
or unipolar, ovoid to fusiform in shape, with a centrally located
nucleus. In those neurons containing only l-GnRH-III, the
reaction product was observed in the cytoplasm of the perikarya
and within their extending processes. In some of the neurons
coexpressing both peptides, the l-GnRH-III reaction product
was mainly observed in the processes of the neuron, whereas the
LHRH appeared to be localized to the cytoplasm of the
perikarya. However, we also visualized neurons that did not
show that distinction, in that both colors were found throughout
the cytoplasm and processes.
Caudal to the organum vasculosum lamina terminalis (OVLT)
region, a discrete population of l-GnRH-III cells was observed
in an area between the dorsal border of the third ventricle and
the ventral borders of the anterior commissure (Fig. 2 A and B).
Perikarya containing m-LHRH were not detected in this region.
Fig. 2. Localization of l-GnRH-III and m-LHRH in the caudal region of the POA. (A) Frontal section showing the distribution of immunoreactive l-GnRH-III neurons
(black dots), m-LHRH neurons (open circles), neurons that coexpress both peptides (asterisks), and fibers of both peptides (dotted lines). Note that l-GnRH-III
neurons are observed in the dorsomedial and lateral POA. In the lateral region of the POA, the l-GnRH-III are observed dorsal to the neurons that are
immunopositive for m-LHRH or both peptides. (B) L-GnRH-III neurons observed in the dorsomedial region of the POA above the third ventricle (V). (C)
Representative neurons immunopositive for l-GnRH-III (red arrow), m-LHRH (black arrow), and both peptides (arrowheads) located in the lateral POA. (B,242;
C, 289.)
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In the lateral POA of this same region (Fig. 2C), neurons were
detected that were immunopositive for l-GnRH-III and m-
LHRH, and an occasional neuron coexpressed both peptides.
The l-GnRH-III neurons were found to be dorsal to those
neurons containing either m-LHRH only or both peptides.
In the rostral hypothalamus near the borders of the supraoptic
nuclei, neurons were detected that mainly contained m-LHRH
only, but occasionally, neurons were observed that colocalized
both peptides (Fig. 3A). Dorsolateral to these neurons, we
observed another small population of neurons containing only
l-GnRH-III immunoreactivity (Fig. 3B).
Immunopositive l-GnRH-III nerve fibers were observed ros-
trally within the OVLT (Fig. 1 A), and caudally within both
medial and lateral POA, passing along the third ventricle and
ventrally along the optic chiasm (Figs. 2 and 3). Positive fibers
were also observed in the intermediate hypothalamus, mostly
within the ventromedial and arcuate nuclei and ventrally along
the base of the brain above the optic chiasm and extending just
lateral to the borders of the supraoptic nucleus. Numerous fibers
were observed coursing ventrally into the ME. Fig. 4A illustrates
the localization of immunoreactive l-GnRH-III material in the
ME. Fiber staining was observed throughout the rostro-caudal
extent of the ME. Immunoreactive fibers were also observed in
the mammillary bodies and into the periaqueductal region of the
mesencephalon, although they were few in number. This fiber
distribution is essentially the same as that which is known for
m-LHRH. We observed that the relative density of immuno-
positive fibers for l-GnRH-III in the ME was visualized to be less
than that of those fibers that were immunopositive for m-LHRH.
Fig. 4B shows that immunoabsorption of the l-GnRH-III
antiserum with 1 g of the l-GnRH-III peptide completely
eliminated nerve fiber and neuronal staining (see Fig. 4A for
comparison). As shown in Fig. 4 C and D, nerve fiber staining
was unaltered when the antiserum was absorbed with 1 g of
m-LHRH and l-GnRH-I, respectively. Absorption with l g of
c-GnRH-II decreased staining of fibers by about 60%.
Discussion
In earlier studies, Stopa et al. showed a lamprey-like GnRH in
human hypothalami and ME by using a combination of immu-
nocytochemistry, HPLC, and RIA (3). The distribution of the
immunopositive l-GnRH-like neurons and fibers was similar to
that observed for m-LHRH. We have also described previously
a population of immunoreactive l-GnRH-like neurons in the rat
ventromedial POA with axons projecting to the OVLT (8).
Dorsomedial l-GnRH-like perikarya were also located in the
caudal preoptic area, with axons projecting caudally and ven-
trally to the ME. Conversely, by using a monoclonal antiserum
against m-LHRH, we determined the localization of m-LHRH
neurons in the regions where the 1-GnRH neurons were ob-
served. Adjacent sections of the ventral POA region revealed
that both peptides were localized in neurons within this area, but
there were no m-LHRH neurons in the dorsomedial or dorso-
lateral POA where perikarya of l-GnRH were observed (8).
Furthermore, immunoabsorption of the primary antiserum dem-
onstrated that the staining of l-GnRH-like neurons was elimi-
nated by the addition of the l-GnRH-III peptide, but not by the
addition of either m-LHRH or l-GnRH-I. Nerve fibers in the
ME were eliminated by absorption with l-GnRH-III, but only
slightly reduced by absorption with m-LHRH. Because the
l-GnRH antiserum (no. 3952) recognized l-GnRH-I and l-
GnRH-III equally, a specific antiserum against l-GnRH-III
without cross-reactivity with l-GnRH-I was needed to show that
the l-GnRH-like neurons visualized in the rat brain were indeed
l-GnRH-III neurons.
The present study indicates that an antiserum specific for
l-GnRH-III (no. 39-82-78-3) binds the same populations of
neurons seen with the less specific l-GnRH antiserum (no. 3952).
Additionally, we now describe another population of l-GnRH-III
neurons in the rostral hypothalamus, dorsolateral to the borders
of the supraoptic nuclei. Also, the staining of neurons and fibers
with this new antiserum could be eliminated by preabsorption
with the l-GnRH-III peptide, but was not affected by preab-
sorption with l-GnRH-I or m-LHRH. Although preabsorption
with c-GnRH-II reduced staining somewhat, probably because
this peptide has 80% homology with l-GnRH-III, there are
virtually no c-GnRH-II neuronal fibers in the ME. Importantly,
this study shows a close relationship between two different forms
of GnRH in the mammal, in that l-GnRH-III and m-LHRH are
colocalized in neurons in the ventral POA and the rostral
hypothalamus. Interestingly, the OVLT area of the POA has
been shown to contain FSH-releasing activity by bioassay (15).
We have shown here that this region contains an abundance of
LHRH neurons, as well as cells that express both peptides.
Lesions in this region eliminate the preovulatory type of LH but
not FSH release (15). This type of LH release has been thought
to be due to LHRH release; however, the presence of l-GnRH-
III neurons in the area and neurons that express both peptides
suggests an interaction of these two peptides to either amplify or
reduce the preovulatory surge of FSH and LH. Further exper-
iments are needed to clarify this interrelationship. In addition to
the neurons that contained both peptides, neurons that contain
only l-GnRH-III or m-LHRH were also observed in these same
areas.
These isolated l-GnRH-III neuronal populations suggest that
these cells may play a separate role in the control of FSH release.
First, the region encompassed by the dorsomedial and dorso-
lateral neurons includes or is just rostral to the region that, when
stimulated, induced selective FSH release (16) and, when de-
stroyed, interfered with pulsatile FSH release (17, 18). Addi-
tionally, of the GnRH isoforms tested in vivo, l-GnRH-III is the
only one that can selectively release FSH with a high degree of
potency (9), an action that was not shared by other GnRH forms,
except for c-GnRH-II, which had only a slight preferential
FSH-releasing activity (12). Recently, FSH-releasing activity was
eluted from Sephadex columns in a fraction that contained
immunoassayable l-GnRH (19). The FSH-releasing activity of
this fraction was abolished by the same antiserum used for
immunoassay and immunocytochemistry in our previous study
(8). This antiserum crossreacts with both l-GnRH-I and -III;
however, l-GnRH-I has little selective gonadotropin-releasing
Fig. 3. Distribution of immunoreactive l-GnRH-III and m-LHRH in the rostral
hypothalamus. (A) Diagram of a frontal section showing the distribution of
immunoreactive l-GnRH-III (black dots), m-LHRH (open circles), both peptides
(asterisks), and fibers (dotted lines). (B) L-GnRH-III neurons (red arrows) dor-
solaterally to the borders of the supraoptic nuclei. Neurons containing both
peptides (arrowheads) or containing only m-LHRH (black arrow) were de-
tected ventral to l-GnRH-III neurons. (B, 251.)







action. Therefore, we believe that the FSH-releasing ability of
this fraction was caused by l-GnRH-III. Final proof awaits
isolation and determination of the structure of follicle-
stimulating hormone releasing factor.
Further evidence of a separate control of FSH release has
been demonstrated in studies by using drugs, such as alcohol (20,
21) and delta-9-tetrahydrocannibanol (22), that eliminate pul-
satile LH release without affecting FSH release. Cytokines, such
as interleukin-1, have also been shown to act centrally to
selectively inhibit LH release without affecting FSH secretion
(23). Thus, the neuronal populations that contain only l-GnRH-
III may control the selective release of FSH, whereas those that
contain both peptides work in concert to control the simulta-
neous pulses of FSH and LH.
Another GnRH isoform that is localized in the mammalian
hypothalamus and midbrain is c-GnRH-II. Previously, we used
a c-GnRH-II antiserum, which has been shown to detect this
peptide in chicken brain (24) and found that there was no
c-GnRH-II neuronal or fiber staining in the hypothalamus of the
rat (8). Recently, after using an amplification technique, we were
able to detect scant immunopositive c-GnRH-II fibers, but again
no perikarya, in the POA, as well as the hypothalamicME
region of the rat (J.K.H. and W.L.D., unpublished observation).
We did, however, detect a few immunopositive c-GnRH-II cells
in the mesencephalon. This result was similar to the staining
observed in the musk shrew (6), although, in our hands we did
not detect fibers in the mammillary region and only a few fibers
in the mesencephalon, whereas abundant fibers of c-GnRH-II
were described in these regions of the shrew. Importantly, others
(7) have not observed immunopositive c-GnRH-II neurons in
the hypothalamus of the normal mouse. Conversely, in the
hypogonadal mouse lacking m-LHRH, c-GnRH-II cells have
been detected in the arcuate nucleus. Since the c-GnRH-II
antiserum was conjugated to BSA (25) and because the study
does not indicate that the anti-BSA activity was absorbed (26),
these putative c-GnRH-II cells found in the arcuate nucleus may
represent BSA stained cells by the anti-BSA antibodies within
the antiserum and not c-GnRH-II neurons. Similar false-positive
results for the localization of GnRH have been previously
demonstrated by using an antiserum generated against GnRH-
BSA hapten-conjugates (27).
Additionally, the morphology and distribution of c-GnRH-II
neurons and fibers is different from that of m-LHRH and
l-GnRH-III. C-GnRH-II cells are described as round in shape
and smaller in size than m-GnRH neurons (4, 6, 7), whereas
l-GnRH-III neurons have a similar morphology as that of
Fig. 4. Frontal sections through the middle region of the ME showing the efficiency of immunoabsorption of the l-GnRH-III antiserum. (A) Positive staining
after tissue incubation with unabsorbed primary antiserum. (B) The ability of 1 g of l-GnRH-III to eliminate fiber staining; C and D demonstrate clearly that
preabsorption with 1g of m-LHRH (C) or 1g of l-GnRH-1 (D) does not diminish the immunoreactivity when compared with the l-GnRH-III unabsorbed antiserum
(A). (A–D, 141.)
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m-LHRH neurons. Both types of these neurons are oval to
diffuse in shape and are similar in size (8).
The distribution of c-GnRH-II cells has been shown in several
studies to differ from the distribution of m-LHRH cells. In the
musk shrew and mouse, it has been demonstrated, by using
immunocytochemistry, that there is no overlap in the distribu-
tion of neurons containing c-GnRH-II and m-LHRH (6, 7). In
the primate, by using in situ hybridization, Latimer et al. detected
c-GnRH-II mRNA in the hypothalamus, but determined it was
not colocalized with m-LHRH (5). Furthermore, immunocyto-
chemical localization of c-GnRH-II perikarya and fibers was not
reported, raising the possibility that the mRNA was not trans-
lated into the peptide (5). In an earlier study, using fetal primate
brains, c-GnRH-II was detected in only a few neurons and fibers
in the caudal hypothalamus, suggesting that this peptide may not
reach the pituitary via the portal vessels (4), and may not play
a role in gonadotropin release.
In summary, we report the colocalization of l-GnRH-III with
m-LHRH, together with localized separate populations of l-
GnRH-III and m-LHRH neurons in the ventromedial preoptic
area, a region known to control the preovulatory release of
gonadotropins (15). These observations suggest that both pep-
tides are cooperating to control the preovulatory surge of LH
and to a lesser extent FSH.
The dorsomedial caudal POA is known to control the selective
release of FSH, based on lesion and stimulation studies (16–18).
This area contains only perikarya of l-GnRH-III neurons. The
axons of both m-LHRH and l-GnRH-III neurons project to the
ME, releasing the peptides into the capillaries of the hypophysial
portal vessels, which transport them to the anterior pituitary
where l-GnRH-III preferentially releases FSH, and m-LHRH
preferentially releases LHRH.
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